flupirtine

DRUG2 trials

Sponsors

Charite University, Berlin, Germany, Ludwig-Maximilians - University of Munich

Conditions

Axonal Change, NeuronalPainRelapsing Remitting Multiple Sclerosis

Phase 1

Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo

CompletedNCT01450865

Ludwig-Maximilians - University of MunichAxonal Change, Neuronal, Pain

Start: 2009-10-31End: 2010-08-31Updated: 2015-01-13

Phase 2

Flupirtine as Oral Treatment in Multiple Sclerosis

TerminatedNCT00623415

Charite University, Berlin, GermanyRelapsing Remitting Multiple Sclerosis

Start: 2007-12-31End: 2012-11-30Updated: 2018-03-20

Related Papers

Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.

2013-02-0811 citations